Literature DB >> 18402769

Rational design of minimal hypoxia-inducible enhancers.

Stefan Kaluz1, Milota Kaluzová, Eric J Stanbridge.   

Abstract

The hypoxia-inducible factor (HIF) activates transcription via binding to the highly variable hypoxia-responsive elements (HREs). All hypoxia-inducible constructs described to date utilize multimers of naturally occurring HREs. Here, we describe the rational design of minimal hypoxia-inducible enhancers, conceptually equivalent to using an optimized HIF-binding site (HBS) as the building block. Optimizations of the HBS, spacing between HBSs, the distance from the minimal promoter, and orientation of HBSs allowed us to design constructs with high hypoxic activity. Activation of the 4xopt HBS (36bp) construct by hypoxia or HIF-1alpha and HIF-2alpha was comparable with that of the 4xEPO HRE (208bp) construct. The strong synergism between the properly arranged optimized HBSs was due to stimulation of high affinity HIF binding. Our data prove, for the first time, that it is possible to assemble artificial hypoxia-inducible enhancers from a single type of regulatory element-optimized HBS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18402769      PMCID: PMC2647722          DOI: 10.1016/j.bbrc.2008.03.147

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma.

Authors:  Q Shi; X Le; J L Abbruzzese; Z Peng; C N Qian; H Tang; Q Xiong; B Wang; X C Li; K Xie
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

2.  Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells.

Authors:  D E Post; E G Van Meir
Journal:  Gene Ther       Date:  2001-12       Impact factor: 5.250

3.  Characterization of physiologically regulated vectors for the treatment of ischemic disease.

Authors:  K Boast; K Binley; S Iqball; T Price; H Spearman; S Kingsman; A Kingsman; S Naylor
Journal:  Hum Gene Ther       Date:  1999-09-01       Impact factor: 5.695

4.  Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide.

Authors:  H Kimura; A Weisz; T Ogura; Y Hitomi; Y Kurashima; K Hashimoto; F D'Acquisto; M Makuuchi; H Esumi
Journal:  J Biol Chem       Date:  2000-10-30       Impact factor: 5.157

5.  Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer.

Authors:  Stefan Kaluz; Milota Kaluzová; Eric J Stanbridge
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

6.  DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.

Authors:  Milota Kaluzová; Stefan Kaluz; Michael I Lerman; Eric J Stanbridge
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

7.  The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1.

Authors:  D L Galson; T Tsuchiya; D S Tendler; L E Huang; Y Ren; T Ogura; H F Bunn
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

8.  Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein.

Authors:  B L Ebert; H F Bunn
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

9.  Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation.

Authors:  Cheng-Jun Hu; Li-Yi Wang; Lewis A Chodosh; Brian Keith; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  Regulation of a rat VL30 element in human breast cancer cells in hypoxia and anoxia: role of HIF-1.

Authors:  K Ameri; B Burke; C E Lewis; A L Harris
Journal:  Br J Cancer       Date:  2002-11-04       Impact factor: 7.640

View more
  15 in total

Review 1.  Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?

Authors:  Stefan Kaluz; Milota Kaluzová; Shu-Yuan Liao; Michael Lerman; Eric J Stanbridge
Journal:  Biochim Biophys Acta       Date:  2009-01-22

2.  Improvement and induction property of radiation-responsive promoter through DNA shuffling of 5'-flanking regions of the human p21 gene.

Authors:  Go Kagiya; Ryohei Ogawa; John A Cook; Rajani Choudhuri; Masanori Hatashita; Yoshikazu Tanaka; Bill G DeGraff; James B Mitchell
Journal:  J Biosci Bioeng       Date:  2010-02-04       Impact factor: 2.894

3.  Transcription factor HIF1A: downstream targets, associated pathways, polymorphic hypoxia response element (HRE) sites, and initiative for standardization of reporting in scientific literature.

Authors:  Lucija Slemc; Tanja Kunej
Journal:  Tumour Biol       Date:  2016-09-19

Review 4.  Molecular and Supramolecular Structure of the Mitochondrial Oxidative Phosphorylation System: Implications for Pathology.

Authors:  Salvatore Nesci; Fabiana Trombetti; Alessandra Pagliarani; Vittoria Ventrella; Cristina Algieri; Gaia Tioli; Giorgio Lenaz
Journal:  Life (Basel)       Date:  2021-03-15

5.  Glucocorticoids promote Von Hippel Lindau degradation and Hif-1α stabilization.

Authors:  Andrea Vettori; David Greenald; Garrick K Wilson; Margherita Peron; Nicola Facchinello; Eleanor Markham; Mathavan Sinnakaruppan; Laura C Matthews; Jane A McKeating; Francesco Argenton; Fredericus J M van Eeden
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-29       Impact factor: 11.205

Review 6.  Relevance of mitochondrial genetics and metabolism in cancer development.

Authors:  Giuseppe Gasparre; Anna Maria Porcelli; Giorgio Lenaz; Giovanni Romeo
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

Review 7.  PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases.

Authors:  Xuemin He; Rui Cheng; Siribhinya Benyajati; Jian-xing Ma
Journal:  Clin Sci (Lond)       Date:  2015-06       Impact factor: 6.124

8.  Bortezomib attenuates HIF-1- but not HIF-2-mediated transcriptional activation.

Authors:  Noraini Abd-Aziz; Eric J Stanbridge; Norazizah Shafee
Journal:  Oncol Lett       Date:  2015-07-29       Impact factor: 2.967

9.  Construction of PR39 recombinant AAV under control of the HRE promoter and the effect of recombinant AAV on gene therapy of ischemic heart disease.

Authors:  Lijun Sun; Yuewen Hao; Xiaowei Nie; Xuexin Zhang; Guangxiao Yang; Quanying Wang
Journal:  Exp Ther Med       Date:  2012-08-20       Impact factor: 2.447

10.  Suppressors of superoxide production from mitochondrial complex III.

Authors:  Adam L Orr; Leonardo Vargas; Carolina N Turk; Janine E Baaten; Jason T Matzen; Victoria J Dardov; Stephen J Attle; Jing Li; Douglas C Quackenbush; Renata L S Goncalves; Irina V Perevoshchikova; H Michael Petrassi; Shelly L Meeusen; Edward K Ainscow; Martin D Brand
Journal:  Nat Chem Biol       Date:  2015-09-14       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.